| Net loss | -653.01K |
| Purchased in-process research and development | |
| Write-off of acquired technology | |
| Interest expense settled through issuance of notes payable | |
| Net gain on early extinguishment of debt | |
| Non-cash interest expense | |
| Non-cash charges related to options, warrants and common stock | |
| Amortization of financing costs | |
| Amortization and depreciation | 0 |
| Decrease (increase) in prepaid expenses and other current assets | -22K |
| (Decrease) increase in accounts payable and accrued expenses | 47.73K |
| Increase in accrued interest payable | 4.79K |
| Decrease in accrued lease | |
| Net cash used for operating activities | -657.51K |
| Cash acquired through Merger | |
| Purchases of fixed assets | |
| Decrease (increase) in security deposits and other assets | |
| Decrease (increase) in indemnity fund | |
| Purchases of marketable securities | |
| Sales and maturities of marketable securities | 0 |
| Net cash provided by (used for) investing activities | 0 |
| Proceeds from issuance of common stock | |
| Buyback of common stock | |
| Proceeds from issuance of preferred stock | |
| Preferred stock conversion inducement | |
| Proceeds from issuance of promissory notes | 590K |
| Proceeds from issuance of convertible debentures | |
| Principal payments of notes payable | |
| Dividend payments on Series E Cumulative Convertible Preferred Stock | |
| Payments of financing costs | |
| Net cash provided by financing activities | 590K |
| Net (decrease) increase in cash and cash equivalents | -67.51K |
| Cash and cash equivalents, beginning of period | 113.96K |
| Cash and cash equivalents, end of period | 46.44K |
| Cash paid for interest | |
| Supplemental disclosure of non-cash financing activity: | |
| Conversion of convertible redeemable preferred stock to common stock | |
| Cumulative accrued interest reversed | |
| Supplemental disclosure of non-cash financing activity: | |
| Number of shares of convertible redeemable preferred stock converted into common stock | |
| Conversion of convertible redeemable preferred stock with a total stockholders' equity value | |